Characterizing GLP-1 Receptor Agonist Use in Preadolescent and Adolescent Populations
This cross-sectional study examines the characteristics of preadolescent and adolescent populations who received glucagon-like peptide-1 (GLP-1) receptor agonists.
Authors
- Pamela B. Davis (ORCID: https://orcid.org/0000-0002-7113-5338)
- Pauline Terebuh (ORCID: https://orcid.org/0000-0002-0129-5109)
- Mark Steven Miller (ORCID: https://orcid.org/0000-0003-1191-0977)
- Rong Xu (ORCID: https://orcid.org/0000-0003-3127-4795)
- David C. Kaelber (ORCID: https://orcid.org/0000-0001-7855-9515)
Institutions
- MetroHealth (US)
- University School (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.39887
- Citations
- 15
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.37